TG Therapeutics Inc logo

TG Therapeutics Inc

FRA:NKB2 (USA)   Ordinary Shares
€ 15.59 (-4.58%) May 24
77.18
P/B:
16.39
Market Cap:
€ 2.39B ($ 2.59B)
Enterprise V:
€ 2.30B ($ 2.49B)
Volume:
-
Avg Vol (2M):
148.00
Also Trade In:

TG Therapeutics Inc Operating Data

TG Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

TG Therapeutics Inc (FRA:NKB2) Operating Data Charts